NFKB1 and metabolic syndrome: The present study aimed to examine the connection between Nrf2 as a critical regulator of defense against oxidative stress, NF-κB, a transcription factor mediating the inflammatory response, HO-1, endothelial protector and antioxidant, plasma ADMA, and MDA in people with MetS.